Industry: Pooled Investment Fund (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-14 | Amended | $18,828,480,815 | Unknown | Other | SEC link | |
| 2024-08-14 | Amended | $18,802,108,675 | $9,782,642 | Other | 06b 3C 3C.7 | SEC link |
| 2023-08-16 | Amended | $18,792,326,033 | $4,750,000 | Other | 06b 3C 3C.7 | SEC link |
| 2023-05-15 | Amended | $18,787,576,033 | $21,000,000 | Other | 06b 3C 3C.7 | SEC link |
| 2022-08-23 | Amended | $18,766,576,033 | $7,909,958 | Other | 06b 3C 3C.7 | SEC link |
| 2022-01-14 | Amended | $18,758,666,075 | $94,579,788 | Other | 06b 3C 3C.7 | SEC link |
| 2021-01-15 | Amended | $18,664,086,287 | $260,421,901 | Other | 06b 3C 3C.7 | SEC link |
| 2020-01-15 | Amended | $18,403,664,386 | $91,770,334 | Other | 06b 3C 3C.7 | SEC link |
| 2019-11-08 | Amended | $18,311,894,052 | $783,163,077 | Other | 06b 3C 3C.7 | SEC link |
| 2019-03-18 | Amended | $17,528,730,975 | $1,685,392,339 | Other | 06b 3C 3C.7 | SEC link |
| 2018-03-16 | Amended | $15,843,338,636 | $2,243,789,852 | Other | 06b 3C 3C.7 | SEC link |
| 2017-03-16 | Amended | $13,599,548,784 | $2,443,440,333 | Other | 06b 3C 3C.7 | SEC link |
| 2016-03-16 | Amended | $11,156,108,451 | $924,291,373 | Other | 06b 3C 3C.7 | SEC link |
| 2015-03-16 | Amended | $10,231,817,078 | $419,676,137 | Other | 06b 3C 3C.7 | SEC link |
| 2014-03-14 | Amended | $9,812,140,941 | $354,298,286 | Other | 06b 3C 3C.7 | SEC link |
| 2013-03-14 | Amended | $9,457,842,655 | $5,604,185,875 | Other | 06 3C 3C.7 | SEC link |
| 2012-03-14 | New | $3,853,656,780 | $3,853,656,780 | Other | 06 3C 3C.7 | SEC link |
| Name | Role |
|---|---|
| Dr. Paul Broder | Director |
| Peter P. Brophy | Executive |
| Dr. Peter F. Brown | Director, Executive |
| Brian Felczak | Executive |
| Mark Heising | Director |
| Edward Hubner | Executive |
| Dr. Henry Laufer | Director |
| Dr. David Lippe | Director, Executive |
| Dr. Robert Lourie | Director |
| Dr. Robert L. Mercer | Executive |
| Tiffany T. Michel | Executive |
| James S. Rowen | Executive |
| Mark Silber | Director |
| Dr. Marilyn Simons | Director |
| Dr. James H. Simons | Director |
| Nathaniel H. Simons | Director |
| Anne K. Small | Director, Executive |
| Dr. Alan Stange | Director |